November 4, 2021

Ryvu’s partner Menarini Group receives FDA Orphan Drug Designation for SEL24 (MEN1703) for the Treatment of Acute Myeloid Leukemia

Year

2021

Assets in this page

Download assets

  • pdf file

    Current Report ESPI 33/2021

    Download